HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The reverse activity of human acid ceramidase.

Abstract
An overexpression system was recently developed to produce and purify recombinant, human acid ceramidase. In addition to ceramide hydrolysis, the purified enzyme was able to catalyze ceramide synthesis using [14C]lauric acid and sphingosine as substrates. Herein we report detailed characterization of this acid ceramidase-associated "reverse activity" and provide evidence that this reaction occurs in situ as well as in vitro. The pH optimum of the reverse reaction was approximately 5.5, as compared with approximately 4.5 for the hydrolysis reaction. Non-ionic detergents and zinc cations inhibited the activity, whereas most other cations were stimulatory. Of note, sphingomyelin also was very inhibitory toward this reaction, whereas the anionic lipids, phosphatidic acid and phosphatidylserine, were stimulatory. Of various sphingosine stereoisomers tested in the reverse reaction, only the natural, D-erythro form could efficiently serve as a substrate. Using D-erythro-sphingosine and lauric acid as substrates, the reaction followed normal Michaelis-Menten kinetics. The Km and Vmax values toward sphingosine were 23.75 microM and 208.3 pmol/microg/h, respectively, whereas for lauric acid they were 73.76 microM and 232.5 pmol/microg/h, respectively. Importantly, the reverse activity was reduced in cell lysates from a Farber disease patient to the same extent as the acid ceramidase activity. Furthermore, when 12-(N-methyl-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)) (NBD)-conjugated lauric acid and sphingosine were added to cultured lymphoblasts from a Farber disease patient in the presence of fumonisin B (1), the conversion to NBD-ceramide was reduced approximately 30% when compared with normal cells. These data provide important new information on human acid ceramidase and further document its central role in sphingolipid metabolism.
AuthorsNozomu Okino, Xingxuan He, Shimon Gatt, Konrad Sandhoff, Makoto Ito, Edward H Schuchman
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 278 Issue 32 Pg. 29948-53 (Aug 08 2003) ISSN: 0021-9258 [Print] United States
PMID12764132 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cations
  • Detergents
  • Fumonisins
  • Lauric Acids
  • Recombinant Proteins
  • Sphingolipids
  • Sphingomyelins
  • lauric acid
  • fumonisin B1
  • Sodium Chloride
  • Galactosylgalactosylglucosylceramidase
  • Amidohydrolases
  • ASAH1 protein, human
  • Acid Ceramidase
  • Ceramidases
  • Zinc
  • Sphingosine
Topics
  • Acid Ceramidase
  • Amidohydrolases (metabolism)
  • Animals
  • CHO Cells
  • Cations
  • Cells, Cultured
  • Ceramidases
  • Cloning, Molecular
  • Cricetinae
  • Detergents (pharmacology)
  • Dose-Response Relationship, Drug
  • Fumonisins (pharmacology)
  • Galactosylgalactosylglucosylceramidase (metabolism, physiology)
  • Humans
  • Hydrogen-Ion Concentration
  • Hydrolysis
  • Kinetics
  • Lauric Acids (chemistry, pharmacology)
  • Lipid Metabolism
  • Lymphocytes (metabolism)
  • Lysosomal Storage Diseases (metabolism)
  • Microscopy, Fluorescence
  • Recombinant Proteins (chemistry)
  • Sodium Chloride (pharmacology)
  • Sphingolipids (metabolism)
  • Sphingomyelins (chemistry)
  • Sphingosine (chemistry)
  • Substrate Specificity
  • Zinc

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: